About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Atrial Fibrillation and Diabetes Mellitus | Clinical Trials | Clareo Health

Back to clinical trial search

UNKNOWNNCT05873920

Atrial Fibrillation and Diabetes Mellitus

Single center prospective study to analyze the impact of diabetes mellitus on patients' outcome following radiofrequency-guided catheter ablation for atrial fibrillation.

Lead sponsor: Heart and Diabetes Center North-Rhine Westfalia•1 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Contacts

Denise Guckel, MD

CONTACT

49 5731 971258 [email protected]

Astrid Kleemeyer

CONTACT

49 5731 971258 [email protected]

Sponsors

Lead Sponsor

Heart and Diabetes Center North-Rhine Westfalia

A total number of 50 patients with diabetes mellitus will undergo radiofrequency-guided catheter ablation for atrial fibrillation. Pre-procedural cardiac MRI will be performed with late-gadolinium enhancement to visualize the individual amount and distribution of fibrosis in the right and left atrium. The relationship between diabetes mellitus and individual atrial arrhythmia substrates as well as patients' outcome following catheter ablation will be analyzed.

Age

18 - No limit years

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•Patients undergoing their 1st radiofrequency-guided catheter ablation for atrial fibrillation
•Diabetes mellitus
•Able to understand and willing to sign the Informed Consent Form.
•Age ≥18 years.

Exclusion Criteria

•Contraindication for DE-MRI with a full dose of gadolinium-based contrast agent.
•Previous left atrial ablation or surgical procedure
•Women currently pregnant, breastfeeding, or of childbearing age not currently taking or not willing to use a reliable form of contraception
•Mental or physical inability to take part in the study
•Morbid obesity (BMI \> 35), or inability to be placed in MRI due to body mass.

Related studies

Predictive Value of Right Atrial Strain in Postoperative Atrial Fibrillation in Patients Undergoing Cardiac Surgery

NCT06054360 · Postoperative Atrial Fibrillation, Strains

RECRUITINGPhase 3

Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Pathogenic TTR Variant

NCT06563895 · Amyloidosis, Amyloid Cardiomyopathy, and more

CLOT-LESS - CLOsure Tailored: LEss Antithrombotic Strategy After LAAC for Stroke Prevention

NCT07575867 · Atrial Fibrillation, Stroke Prevention in Patients With Atrial Fibrillation, and more

PROSPective Evaluation of Outcome After CatheTer Ablation in Atrial Fibrillation

NCT05009797 · Atrial Fibrillation

Grid eXplore Mapping Study

NCT07421076 · Paroxysmal Atrial Fibrillation (PAF)

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: May 24, 2023Terms

Trial snapshot

StatusUNKNOWN

Phase—

Enrollment50

Start dateMay 2023

Last updatedMay 24, 2023

Condition

Atrial Fibrillation Arrhythmias, Cardiac Heart Diseases Cardiovascular Diseases Pathologic Processes

Locations shown

Herz- und Diabeteszentrum NRW

Bad Oeynhausen

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: May 24, 2023Data synced to Clareo: June 27, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions